Date published: 2025-12-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Fmoc-Glu-OAll (CAS 144120-54-7)

0.0(0)
Write a reviewAsk a question

CAS Number:
144120-54-7
Molecular Weight:
409.43
Molecular Formula:
C23H23NO6
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Fmoc-Glu-OAll is a versatile and novel amino acid derivative that holds great potential for scientific research and laboratory experiments. It consists of an Fmoc group, Glutamate group (Glu), and OAll group (ortho-amino-linker). This compound has been extensively studied for its applications in peptide and protein synthesis, enzyme-substrate interactions, small molecule synthesis, and protein-protein interactions. The Fmoc group serves as a protecting group, while the Fmoc-Glu-OAll group plays a role in enzymatic reactions. The OAll group acts as a linker, facilitating the formation of larger molecules. The unique properties of Fmoc-Glu-OAll make it a promising candidate for further investigation and advancements in various biochemical and physiological processes.


Fmoc-Glu-OAll (CAS 144120-54-7) References

  1. Solid-phase synthesis of tailed cyclic RGD peptides using glutamic acid: unexpected glutarimide formation.  |  Zhu, J. and Marchant, RE. 2008. J Pept Sci. 14: 690-6. PMID: 18085515
  2. Subnanomolar antisense activity of phosphonate-peptide nucleic acid (PNA) conjugates delivered by cationic lipids to HeLa cells.  |  Shiraishi, T., et al. 2008. Nucleic Acids Res. 36: 4424-32. PMID: 18596083
  3. Design and synthesis of biomimetic hydrogel scaffolds with controlled organization of cyclic RGD peptides.  |  Zhu, J., et al. 2009. Bioconjug Chem. 20: 333-9. PMID: 19191566
  4. Peptide bicycles that inhibit the Grb2 SH2 domain.  |  Quartararo, JS., et al. 2012. Chembiochem. 13: 1490-6. PMID: 22689355
  5. Global analysis of peptide cyclization efficiency.  |  Thakkar, A., et al. 2013. ACS Comb Sci. 15: 120-9. PMID: 23265659
  6. Development of cyclic peptomer inhibitors targeting the polo-box domain of polo-like kinase 1.  |  Murugan, RN., et al. 2013. Bioorg Med Chem. 21: 2623-34. PMID: 23498919
  7. Inhibition of Ras-Effector Interaction by Cyclic Peptides.  |  Wu, X., et al. 2013. Medchemcomm. 4: 378-382. PMID: 23585920
  8. Rational Design of Cyclic Antimicrobial Peptides Based on BPC194 and BPC198.  |  Cirac, AD., et al. 2017. Molecules. 22: PMID: 28672817
  9. Peptide nucleic acid-templated selenocystine-selenoester ligation enables rapid miRNA detection.  |  Sayers, J., et al. 2018. Chem Sci. 9: 896-903. PMID: 29629156
  10. Development of Macrocyclic Peptidomimetics Containing Constrained α,α-Dialkylated Amino Acids with Potent and Selective Activity at Human Melanocortin Receptors.  |  Merlino, F., et al. 2018. J Med Chem. 61: 4263-4269. PMID: 29660981
  11. Cell Penetration Profiling Using the Chloroalkane Penetration Assay.  |  Peraro, L., et al. 2018. J Am Chem Soc. 140: 11360-11369. PMID: 30118219
  12. Effects of Glutamate Arginylation on α-Synuclein: Studying an Unusual Post-Translational Modification through Semisynthesis.  |  Pan, B., et al. 2020. J Am Chem Soc. 142: 21786-21798. PMID: 33337869
  13. A Convenient Chemoenzymatic Preparation of Chimeric Macrocyclic Peptide Antibiotics with Potent Activity against Gram-Negative Pathogens.  |  Wood, TM., et al. 2021. J Med Chem. 64: 10890-10899. PMID: 34283589
  14. First-in-Class Cyclic Temporin L Analogue: Design, Synthesis, and Antimicrobial Assessment.  |  Bellavita, R., et al. 2021. J Med Chem. 64: 11675-11694. PMID: 34296619
  15. Synthesis and Evaluation of a Dimeric RGD Peptide as a Preliminary Study for Radiotheranostics with Radiohalogens.  |  Echigo, H., et al. 2021. Molecules. 26: PMID: 34684688

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Fmoc-Glu-OAll, 1 g

sc-300737
1 g
$87.00

Fmoc-Glu-OAll, 5 g

sc-300737A
5 g
$352.00